Reckitt Benckiser Group (OTCMKTS:RBGLY) Upgraded at Hsbc Global Res

Hsbc Global Res upgraded shares of Reckitt Benckiser Group (OTCMKTS:RBGLYFree Report) from a hold rating to a strong-buy rating in a research note released on Wednesday morning,Zacks.com reports.

A number of other equities analysts also recently weighed in on the stock. JPMorgan Chase & Co. downgraded shares of Reckitt Benckiser Group from an “overweight” rating to a “neutral” rating in a report on Thursday, August 29th. HSBC upgraded shares of Reckitt Benckiser Group from a “hold” rating to a “buy” rating in a report on Wednesday. Citigroup raised shares of Reckitt Benckiser Group to a “strong-buy” rating in a research report on Tuesday, October 1st. Barclays raised shares of Reckitt Benckiser Group to a “strong-buy” rating in a research report on Friday, October 4th. Finally, UBS Group raised shares of Reckitt Benckiser Group to a “strong-buy” rating in a research report on Wednesday, September 18th. Three analysts have rated the stock with a hold rating, one has issued a buy rating and four have assigned a strong buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Buy”.

View Our Latest Stock Report on RBGLY

Reckitt Benckiser Group Stock Up 0.2 %

OTCMKTS RBGLY opened at $12.26 on Wednesday. The company has a current ratio of 0.69, a quick ratio of 0.47 and a debt-to-equity ratio of 0.97. Reckitt Benckiser Group has a 12-month low of $10.24 and a 12-month high of $15.03. The firm’s 50 day moving average is $12.33 and its 200-day moving average is $11.73.

Reckitt Benckiser Group Company Profile

(Get Free Report)

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.

Read More

Analyst Recommendations for Reckitt Benckiser Group (OTCMKTS:RBGLY)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.